VH3810109 (N6LS) in Adults With HIV-1 Who Are ART-Naive-: Phase IIa BANNER Efficacy Data
Background: The broadly neutralizing antibody (bNAb) VH3810109 (N6LS), a CD4-binding site antibody with broad and potent neutralizing activity in vitro, demonstrated robust antiviral effect (median viral load [VL] decline of 1.72 log10 c/mL and maximum viral nadir from baseline [BL] of −2.60 log10 c/mL) when given at 40 mg/kg intravenously (IV) in people with HIV-1…